IFNG and breast neoplasm: In vivo data illustrated that intravenous administration of CBD-IL-12 stimulated sustained IFN-γ levels within tumors, significantly reduced IFN-γ levels in the peripheral circulatory system, attenuated organ damage and exhibited excellent anticancer activity, triggering complete remission of checkpoint inhibitor-resistant breast tumors (139).